Significant association between paraoxonase 1 rs662 polymorphism and coronary heart disease : A meta-analysis in the Chinese population.

Signifikante Assoziation zwischen Paraoxonase-1-rs662-Polymorphismus und koronarer Herzkrankheit : Eine Metaanalyse in der chinesischen Bevölkerung.

Journal

Herz
ISSN: 1615-6692
Titre abrégé: Herz
Pays: Germany
ID NLM: 7801231

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 04 02 2018
accepted: 18 07 2018
revised: 02 06 2018
pubmed: 22 8 2018
medline: 1 7 2020
entrez: 22 8 2018
Statut: ppublish

Résumé

A growing number of studies have suggested that the single nucleotide polymorphism (SNP) rs662 (G>A) in paraoxonase 1 (PON1) is significantly associated with susceptibility to coronary heart disease (CHD) in the Chinese population. To further evaluate the effects of the PON1 RS662 (G>A) polymorphism on the risk of CHD, we performed a meta-analysis in a Chinese population. PubMed, Embase, Wanfang Data, Chinese National Knowledge Infrastructure (CNKI) were searched to identify eligible studies. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate the strength of the associations between RS662 (G>A) and CHD. In the meta-analysis, we identified 14 articles, including a total of 4835 CHD patients and 5111 controls in the Chinese population. Our result showed that overall rs662 (G>A) was significantly associated with susceptibility to CHD in the Chinese population when compared with healthy controls. Furthermore, a G allele suggested an elevated risk of CHD. In the subgroup analyses stratified by ethnicity and geographic areas, significant associations were found in Chinese Han and South China, but not in North China. The present meta-analysis suggests that rs662 (G>A) SNP in PON1 is associated with CHD risk; the G allele might be the risk allele for CHD susceptibility in the Chinese population. However, more research is required to make a definite conclusion.

Sections du résumé

BACKGROUND BACKGROUND
A growing number of studies have suggested that the single nucleotide polymorphism (SNP) rs662 (G>A) in paraoxonase 1 (PON1) is significantly associated with susceptibility to coronary heart disease (CHD) in the Chinese population. To further evaluate the effects of the PON1 RS662 (G>A) polymorphism on the risk of CHD, we performed a meta-analysis in a Chinese population.
METHODS METHODS
PubMed, Embase, Wanfang Data, Chinese National Knowledge Infrastructure (CNKI) were searched to identify eligible studies. Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were used to evaluate the strength of the associations between RS662 (G>A) and CHD.
RESULT RESULTS
In the meta-analysis, we identified 14 articles, including a total of 4835 CHD patients and 5111 controls in the Chinese population. Our result showed that overall rs662 (G>A) was significantly associated with susceptibility to CHD in the Chinese population when compared with healthy controls. Furthermore, a G allele suggested an elevated risk of CHD. In the subgroup analyses stratified by ethnicity and geographic areas, significant associations were found in Chinese Han and South China, but not in North China.
CONCLUSION CONCLUSIONS
The present meta-analysis suggests that rs662 (G>A) SNP in PON1 is associated with CHD risk; the G allele might be the risk allele for CHD susceptibility in the Chinese population. However, more research is required to make a definite conclusion.

Identifiants

pubmed: 30128909
doi: 10.1007/s00059-018-4737-8
pii: 10.1007/s00059-018-4737-8
doi:

Substances chimiques

Aryldialkylphosphatase EC 3.1.8.1
PON1 protein, human EC 3.1.8.1

Types de publication

Journal Article Meta-Analysis Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

347-355

Subventions

Organisme : Yichang Key Laboratory of ischemic cardiovascular and cerebrovascular disease translational medicine foundation
ID : 2017KXN09

Auteurs

Z Deng (Z)

Department of Pharmacy, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People'sHospital, 443000, Yichang, China. dengzhifang@ctgu.edu.cn.

H Xiang (H)

Department of Laboratory Medicine, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People's Hospital, 443000, Yichang, China.

W Gao (W)

Central Experimental Laboratory and Yichang Key Laboratory of Ischemic Cardiovascular and Cerebrovascular Disease Translational Medicine, The First College of Clinical Medical Science, China Three Gorges University and Yichang Central People's Hospital, 443003, Yichang, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH